PPARbeta/delta as a promising molecular drug target for liver diseases: A focused review. Meng X, Wang L, Du YC, Cheng D, et al. Clin Res Hepatol Gastroenterol 2024;48:102343.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meng X, Wang L, Du YC, Cheng D, et al. PPARbeta/delta as a promising molecular drug target for liver diseases: A focused review. Clin Res Hepatol Gastroenterol 2024;48:102343.
PMID: 38641250